Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines

Heterologous “prime-boost” regimens that involve priming with plasmid DNA vaccines and boosting with recombinant viral vectors have been shown to elicit potent virus-specific cytotoxic T-lymphocyte responses. Increasing evidence, however, suggests that the utility of recombinant viral vectors in hum...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Barouch, Dan H., McKay, Paul F., Sumida, Shawn M., Santra, Sampa, Jackson, Shawn S., Gorgone, Darci A., Lifton, Michelle A., Chakrabarti, Bimal K., Xu, Ling, Nabel, Gary J., Letvin, Norman L.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC167238/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12885892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.16.8729-8735.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!